Calendar Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar tracking FDA decisions, clinical trial results, and PDUFA dates for biotech stocks.

Quick Links

Catalyst Calendar
Search Companies
Biotech Glossary
Therapeutic Areas

Legal

About
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

© 2025 CatalystAlert. All rights reserved.

Not financial advice. Data may be delayed or incomplete.

Tebapivat Matched Placebo - Phase 2 | AGIO Pipeline | CatalystAlert

Tebapivat Matched Placebo

Phase 2

Agios Pharmaceuticals, Inc. (AGIO)

23%

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts

May 2026~

AGIOPhase 2Phase 2

Tebapivat Matched Placebo Phase 2 Results Expected

Tebapivat Matched Placebo • Sickle Cell Disease

Drug Information

Target Indication

Sickle Cell Disease

Clinical Trial

Last updated: 12/4/2025

Developer

AGIO

Agios Pharmaceuticals, Inc.

Biotechnology•North America•NASDAQ